Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports

BACKGROUND: Histologic grade of ductal carcinoma in situ of the breast (DCIS) may become the single biomarker that decides whether patients will be treated. Yet, evidence shows that grading variation in daily practice is substantial. To facilitate quality improvement, feedback reports, in which labo...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dooijeweert, Carmen, van Diest, Paul J., Baas, Inge O., van der Wall, Elsken, Deckers, Ivette A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216330/
https://www.ncbi.nlm.nih.gov/pubmed/32393303
http://dx.doi.org/10.1186/s13000-020-00970-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216330/
https://www.ncbi.nlm.nih.gov/pubmed/32393303
http://dx.doi.org/10.1186/s13000-020-00970-8

Ejemplares similares